671 related articles for article (PubMed ID: 18355314)
21. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208.
Klajnert B; Cortijo-Arellano M; Cladera J; Majoral JP; Caminade AM; Bryszewska M
Biochem Biophys Res Commun; 2007 Dec; 364(1):20-5. PubMed ID: 17927954
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion.
Kumar S; Mohanty SK; Udgaonkar JB
J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity of insulin within its self-assembly and amyloidogenic pathways.
Grudzielanek S; Velkova A; Shukla A; Smirnovas V; Tatarek-Nossol M; Rehage H; Kapurniotu A; Winter R
J Mol Biol; 2007 Jul; 370(2):372-84. PubMed ID: 17521669
[TBL] [Abstract][Full Text] [Related]
24. Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p.
Bousset L; Redeker V; Decottignies P; Dubois S; Le Maréchal P; Melki R
Biochemistry; 2004 May; 43(17):5022-32. PubMed ID: 15109261
[TBL] [Abstract][Full Text] [Related]
25. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
[TBL] [Abstract][Full Text] [Related]
26. Structural insights into alternate aggregated prion protein forms.
Polano M; Bek A; Benetti F; Lazzarino M; Legname G
J Mol Biol; 2009 Nov; 393(5):1033-42. PubMed ID: 19720066
[TBL] [Abstract][Full Text] [Related]
27. A cylinder-shaped double ribbon structure formed by an amyloid hairpin peptide derived from the beta-sheet of murine PrP: an X-ray and molecular dynamics simulation study.
Croixmarie V; Briki F; David G; Coïc YM; Ovtracht L; Doucet J; Jamin N; Sanson A
J Struct Biol; 2005 Jun; 150(3):284-99. PubMed ID: 15890277
[TBL] [Abstract][Full Text] [Related]
28. Chaperonin-mediated de novo generation of prion protein aggregates.
Stöckel J; Hartl FU
J Mol Biol; 2001 Nov; 313(4):861-72. PubMed ID: 11697909
[TBL] [Abstract][Full Text] [Related]
29. Methods for conversion of prion protein into amyloid fibrils.
Breydo L; Makarava N; Baskakov IV
Methods Mol Biol; 2008; 459():105-15. PubMed ID: 18576151
[TBL] [Abstract][Full Text] [Related]
30. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
Soto C; Estrada L; Castilla J
Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
[TBL] [Abstract][Full Text] [Related]
31. Atomic force microscopy to characterize the molecular size of prion protein.
Kunze S; Lemke K; Metze J; Bloukas G; Kotta K; Panagiotidis CH; Sklaviadis T; Bodemer W
J Microsc; 2008 May; 230(Pt 2):224-32. PubMed ID: 18445151
[TBL] [Abstract][Full Text] [Related]
32. Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein.
Wille H; Prusiner SB; Cohen FE
J Struct Biol; 2000 Jun; 130(2-3):323-38. PubMed ID: 10940236
[TBL] [Abstract][Full Text] [Related]
33. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
Satheeshkumar KS; Jayakumar R
Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
[TBL] [Abstract][Full Text] [Related]
34. Structural dependence of the cellular isoform of prion protein on solvent: spectroscopic characterization of an intermediate conformation.
Pergami P; Bramanti E; Ascoli GA
Biochem Biophys Res Commun; 1999 Nov; 264(3):972-8. PubMed ID: 10544040
[TBL] [Abstract][Full Text] [Related]
35. Different structural stability and toxicity of PrP(ARR) and PrP(ARQ) sheep prion protein variants.
Paludi D; Thellung S; Chiovitti K; Corsaro A; Villa V; Russo C; Ianieri A; Bertsch U; Kretzschmar HA; Aceto A; Florio T
J Neurochem; 2007 Dec; 103(6):2291-300. PubMed ID: 17919292
[TBL] [Abstract][Full Text] [Related]
36. High pressure promotes circularly shaped insulin amyloid.
Jansen R; Grudzielanek S; Dzwolak W; Winter R
J Mol Biol; 2004 Apr; 338(2):203-6. PubMed ID: 15066425
[TBL] [Abstract][Full Text] [Related]
37. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization.
Kazlauskaite J; Sanghera N; Sylvester I; Vénien-Bryan C; Pinheiro TJ
Biochemistry; 2003 Mar; 42(11):3295-304. PubMed ID: 12641461
[TBL] [Abstract][Full Text] [Related]
38. Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain.
Zurdo J; Guijarro JI; Jiménez JL; Saibil HR; Dobson CM
J Mol Biol; 2001 Aug; 311(2):325-40. PubMed ID: 11478864
[TBL] [Abstract][Full Text] [Related]
39. High-pressure studies on protein aggregates and amyloid fibrils.
Kim YS; Randolph TW; Seefeldt MB; Carpenter JF
Methods Enzymol; 2006; 413():237-53. PubMed ID: 17046400
[TBL] [Abstract][Full Text] [Related]
40. Morphology and secondary structure of stable beta-oligomers formed by amyloid peptide PrP(106-126).
Walsh P; Yau J; Simonetti K; Sharpe S
Biochemistry; 2009 Jun; 48(25):5779-81. PubMed ID: 19476383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
